| Issue Date | Title | Author(s) |
| 2021 | Anti-inflammatory activity of a new dipharmacophore derivative of propionic acid | Slyusarenko, V. S.; Korokin, M. V.; Kovalenko, S. N.; Stadnichenko, A. N.; Korokina, L. V. |
| 2024 | Assessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3- hydroxypyridinium N-acetyltaurinate in the modeling of POAG | Efimenko, S. V.; Korokin, M. V.; Gudyrev, O. S.; Danilenko, L. M.; Korokina, L. V. |
| 2020 | Eleven-amino acid peptides that mimic the erythropoietin α-helix B increases cell survival in endotheliocyte culture | Antsiferov, O. V.; Korokin, M. V.; Gureev, V. V.; Pokrovskii, M. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G. |
| 2022 | Endothelial dysfunction: developmental mechanisms and therapeutic strategies | Shcheblykin, D. V.; Bolgov, A. A.; Pokrovskii, M. V.; Stepenko, Yu. V.; Tsuverkalova, Y. M.; Shcheblykina, O. V.; Korokina, L. V. |
| 2021 | Investigation of allergenic and mutagenic effects of phenolic compound, an arignase-2 inhibitor | Korokina, L. V.; Pokrovskii, M. V.; Kochkarova, I. S.; Pokopeiko, O. N.; Povetkin, S. V. |
| 2018 | Principles of pharmacological correction of pulmonary arterial hypertension | Korokina, L. V.; Zhernakova, N. I.; Korokin, M. V.; Pokopejko, O. N. |
| 2023 | Pulmonary hypertension: modern methods of treatment and ways of their long-term development | Zagrebelnaya, A. V.; Korokina, L. V.; Malorodova, T. N.; Shcheblykina, O. V.; Avtina, T. V.; Bolgov, A. A. |
| 2019 | Search for new pharmacological targets for increasing the efficiency of correction of cardiovascular diseases | Korokina, L. V.; Golubev, I. V.; Pokopejko, O. N.; Zagrebelnaya, A. V.; Demchenko, S. A. |
| 2019 | Study of the selective phenolic inhibitors of arginase 2 acute toxicity | Korokina, L. V.; Pokrovskii, M. V.; Korokin, M. V.; Pokopejko, O. N.; Pokrovskaia, T. G.; Galenko-Yaroshevsky, P. G.; Dolzhikov, A. A.; Reznichenko, L. V.; Yakovleva, E. G. |
| 2020 | The anti-aggregation activity of new 11-amino acid of erythropoietin derivate containing tripeptide motifs | Golubev, I. V.; Gureev, V. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G.; Pokopeiko, O. N. |
| 2023 | The EPOR/CD131 heteroreceptoragonist has an endothelioprotective effect against the background of pulmonary hypertension caused by monocrotalin | Korokina, L. V. |
